Alvotech reports financial results for first three months of 2023 and provides business update

Reykjavik, iceland, may 19, 2023 (globe newswire) -- alvotech (nasdaq: alvo, or the “company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first three months of 2023 and provided a summary of recent corporate highlights.

ALVO Ratings Summary

ALVO Quant Ranking